European registry on inherited platelet disorders project
An SWG Grant-supported project initiated by EHA's SWG on Thrombocytopenia and Platelet Function Disorders.
Project team
            
                
            
            Prof Paolo Gresele
        
        
            
                Professor, Department of Internal Medicine
            
            
                University of Perugia
            
            
                Italy
            
            
            
        
            
                
            
            Prof Jose Rivera Pozo
        
        
            
                Principal Researcher, Clinical-Experimental Hematology and Medical Oncology 
            
            
                Universidad de Murcia and Instituto Murciano De Investigación Biosanitaria
            
            
                Spain
            
            
            
        
            
                
            
            Dr Loredana Bury
        
        
            
                Researcher | Project's Young Investigator
            
            
                University of Perugia
            
            
                Italy
            
            
            
        
Project background and aims
The primary objective of this EHA-SWG-initiated small research project is to establish the first European registry on IPDs.
Inherited platelet disorders (IPD) are a heterogeneous group of rare bleeding diseases. This group is:
- Associated with a reduction of platelet number and/or function
 - Characterized by a bleeding tendency ranging from mild to severe
 
Despite recent significant breakthroughs, IPDs are largely neglected because they're rare and generally considered benign. For this reason, they remain under-diagnosed and their prevalence is still unknown.
Rare disease registries are a way of systematically collecting of data on the diagnosis and management of patients. They allow us to:
- Estimate the prevalence of a disorder
 - Get deeper insight into a disorder's prognosis
 
The potential result of this is that we can improve both diagnosis and management. However, the few existing registries on IPD are set up as independent studies and do not interoperate with one another.
The primary objective of this EHA-SWG-initiated small research project is to establish the first European registry on IPDs (ERIPD). This will:
- Represent the first collection of clinical, laboratory, and genetic data of a large cohort of patients with different forms of IPD from different geographical areas in Europe
 - Provide insights into the real prevalence of these disorders in Europe
 - Help to address unmet needs regarding their impact on patients' lives and healthcare systems
 
Project updates
You can find out more about the status of this project by reading the latest update from Prof Paolo Gresele.